Mott Corporation, a unit of IDEX Corporation, announced on April 17, 2026 that it has entered a partnership with deltaVision to supply high‑performance valve and fluid control solutions to North American spacecraft manufacturers. The collaboration combines deltaVision’s precision valve technology with Mott’s propulsion‑grade filtration, flow restrictors, and integrated flow‑control assemblies, creating a fully integrated, contamination‑controlled propulsion feed‑system component line.
The joint offering is designed to give spacecraft programs shorter lead times for mission‑critical propulsion components. By leveraging deltaVision’s EN 9100‑certified manufacturing and Mott’s AS9100‑certified facilities, the partnership delivers reliable, clean, and mission‑assured valve solutions that operate under extreme thermal, pressure, and corrosive conditions. The integrated product portfolio targets the growing demand for advanced propulsion systems in the U.S. space industry.
For IDEX, the deal expands the Health Science Technologies segment’s aerospace and defense footprint and supports the company’s strategy of integrating high‑margin, high‑growth capabilities into its platform. IDEX’s recent financial performance underscores the strategic fit: Q4 2025 sales rose 4% YoY to $899 million, with adjusted diluted EPS of $2.10, a 3% increase. Full‑year 2025 sales reached $3.5 billion, up 6% from 2024, and adjusted diluted EPS of $7.95, a 1% increase. Guidance for Q1 2026 projects adjusted diluted EPS of $1.73‑$1.78, while full‑year 2026 guidance projects $8.15‑$8.35 in adjusted diluted EPS. The acquisition of Mott in July 2024 for approximately $1 billion (net of tax benefits) laid the groundwork for this partnership.
The partnership positions IDEX to capture a rapidly expanding segment of the U.S. space market, offering a more comprehensive and streamlined product line to spacecraft manufacturers. By integrating valve technology with filtration and flow‑control solutions, IDEX can reduce lead times and enhance product reliability, giving it a competitive edge over rivals such as Triton Space Technologies that also serve the commercial space sector.
The collaboration is expected to strengthen IDEX’s high‑margin aerospace and defense business, complementing its existing portfolio and supporting the company’s broader growth strategy. The partnership aligns with IDEX’s focus on high‑growth, high‑margin capabilities and is likely to contribute positively to the Health Science Technologies segment’s revenue and earnings momentum in the coming quarters.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.